Resultados de la búsqueda 81-90 of 10320 for Resveratrol

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Linvoseltamab has previously been studied as a single agent (without other cancer treatments) in participants with multiple myeloma that returned after prior ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

10. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...